Brief: Gland Pharma Gets US FDA Approval For Cetrorelix Acetate For Injection
29/04/2024 05:56
April 29 (Reuters) - Gland Pharma Ltd GLAD.NS :
* RECEIVES APPROVAL FROM US FDA FOR CETRORELIX ACETATE FOR
INJECTION
* CO EXPECTS TO LAUNCH THE PRODUCT IN NEAR-TERM THROUGH ITS
MARKETING PARTNER
Source text for Eikon: ID:
Further company coverage: GLAD.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gland Pharma
See all newsIndia Stocks: Indian shares open higher as Fed-hike fears, oil prices ease; financials lead
India Stocks: Indian shares poised to rebound as Fed-hike fears, oil prices ease
Brief: Gland Pharma Approves $21 Million Investment In Gland Pharma Usa
Brief: Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln
India's Gland Pharma gains on successful completion of US FDA probe at Visakhapatnam plant